Startup

Gadget Ghupshup

Local Legends

Tech takes

Brokerage

Top Shows

Gold steady as Middle East war lifts oil; palm oil gains, sugar slips

Wheelz Top 10: XEV 9e launch, V-Class return, Bridger teaser, auto sales surge

Oil and Gold Reach Record Highs Amid Massive US-Iran Conflict and Supply Chaos

Zomato shares drop 24%, but Bernstein sees 52% upside

Rising crude oil prices create sectoral divergence in markets

Home

Personal Finance

India

Economy

Tech

Auto

Markets

Jobs

Indian Railways

World

Videos

Photos

https://www.zeebiz.com/market-news/video-gallery-nephroplus-q3-results-profit-growth-fy27-outlook-390292

NephroPlus delivered a strong Q3 performance with profit surging 60.4% to ₹32 crore, driven by operational efficiency, expansion of dialysis centers, and improved occupancy rates. The healthcare company benefited from better cost management and operating leverage, leading to margin expansion. In an exclusive interaction, Founder &amp; CMD Vikram Vuppala highlighted that strategic network expansion and focus on operational excellence were key growth drivers. With rising cases of chronic kidney disease and increasing healthcare spending in India, the company sees strong structural demand tailwinds. Looking ahead to FY27, NephroPlus has provided a positive growth outlook, expecting continued revenue visibility and gradual margin improvement. Technology integration, scale benefits, and efficiency optimization are likely to further strengthen profitability. The Q3 results reinforce NephroPlus’ positioning within India’s growing healthcare services sector, making it a stock to watch in the healthcare earnings space.

Dialysis expansion drives margin growth for Nephroplus

<p>NephroPlus delivered a strong Q3 performance with profit surging 60.4% to ₹32 crore, driven by operational efficiency, expansion of dialysis centers, and improved occupancy rates. The healthcare company benefited from better cost management and operating leverage, leading to margin expansion. In an exclusive interaction, Founder &amp; CMD Vikram Vuppala highlighted that strategic network expansion and focus on operational excellence were key growth drivers. With rising cases of chronic kidney disease and increasing healthcare spending in India, the company sees strong structural demand tailwinds. Looking ahead to FY27, NephroPlus has provided a positive growth outlook, expecting continued revenue visibility and gradual margin improvement. Technology integration, scale benefits, and efficiency optimization are likely to further strengthen profitability. The Q3 results reinforce NephroPlus’ positioning within India’s growing healthcare services sector, making it a stock to watch in the healthcare earnings space.</p>


Dialysis expansion drives margin growth for Nephroplus

Wheelz Top 10: XEV 9e launch, V-Class return, Bridger teaser, auto sales surge

Oil and Gold Reach Record Highs Amid Massive US-Iran Conflict and Supply Chaos

Zomato shares drop 24%, but Bernstein sees 52% upside

Recommended Videos

Gold steady as Middle East war lifts oil; palm oil gains, sugar slips

Wheelz Top 10: XEV 9e launch, V-Class return, Bridger teaser, auto sales surge

Oil and Gold Reach Record Highs Amid Massive US-Iran Conflict and Supply Chaos

other shows